OTCMKTS:PLLWF Polarean Imaging (PLLWF) Stock Price, News & Analysis → Three basic steps to building the Ultimate Dividend Portfolio. (From DTI) (Ad) Free PLLWF Stock Alerts $0.05 0.00 (0.00%) (As of 05/24/2024 ET) Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.05▼$0.0552-Week Range$0.05▼$0.30Volume750,000 shsAverage Volume7,033 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Polarean Imaging alerts: Email Address Ad DarwinGet Ahead in 2024: Key Stocks to Watch!Welcome to a promising year ahead! We're excited to share our carefully curated guide, "Top 9 Stocks to Watch," designed to enhance your investment strategy in 2024. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. Access Your Exclusive Report Now About Polarean Imaging Stock (OTCMKTS:PLLWF)Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.Read More PLLWF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PLLWF Stock News HeadlinesMay 24 at 8:34 AM | bizjournals.comDurham public company raises $10M to accelerate salesFebruary 11, 2024 | morningstar.comPolarean Imaging PLC Ordinary Shares POLXSeptember 7, 2023 | marketwatch.comPolarean Imaging Shares Tumble On Capital Needs AnnouncementSeptember 5, 2023 | marketwatch.comPolarean Imaging's MRI Technology Gets In-Line Price Range for Reimbursement CodeAugust 7, 2023 | proactiveinvestors.comPolarean Imaging chair exercises warrantsAugust 3, 2023 | finance.yahoo.comPolarean Receives Clearance for New MRI Chest CoilJune 21, 2023 | proactiveinvestors.comPolarean Imaging appoints new CEO as Hullihen prepares to retireJune 21, 2023 | marketwatch.comPolarean Imaging Appoints Christopher Von Jako as New CEOJune 21, 2023 | finance.yahoo.comAppointment of Dr. Christopher von Jako as new CEOJune 2, 2023 | marketwatch.comPolarean Imaging Shares Rise on Pact With PhilipsMay 3, 2023 | finance.yahoo.comPolarean to be a featured company at 2023 ATS Respiratory Innovation SummitMarch 13, 2023 | proactiveinvestors.comPolarean calls temporary halt to AIM trading in the wake of SVB collapseFebruary 2, 2023 | proactiveinvestors.comPolarean Imaging hails as a 'major milestone' FDA designation for XENOVIEWFebruary 2, 2023 | proactiveinvestors.comPolarean Imaging hails as a 'major milestone' FDA designation for XENOVIEWFebruary 2, 2023 | proactiveinvestors.comPolarean Imaging hails FDA designation for XENOVIEW as a 'major milestone'February 2, 2023 | proactiveinvestors.comPolarean Imaging hails FDA designation for XENOVIEW as a 'major milestone'February 1, 2023 | marketwatch.comPolarean Imaging Shares Rise After FDA Grant on XenoviewDecember 28, 2022 | marketwatch.comPolarean Imaging's Xenoview Gets US FDA ApprovalSeptember 30, 2022 | proactiveinvestors.comPolarean Imaging updates on FDA reviewSeptember 23, 2022 | lse.co.ukPolarean Imaging shares dive on FDA additional information requestSeptember 22, 2022 | marketwatch.comPolarean Imaging Shares Fall on FDA's Concerns Over Gas Blend DrugAugust 26, 2022 | proactiveinvestors.comPolarean Imaging appoints Dr Marcella Ruddy as non-executive directorAugust 26, 2022 | proactiveinvestors.comPolarean Imaging PLC appoints Dr Marcella Ruddy as non-executive directorAugust 22, 2022 | finance.yahoo.comPolarean Imaging plc (PLLWF)July 8, 2022 | proactiveinvestors.comPolarean Imaging completes system installation at Cincinnati Children's Hospital Medical CenterSee More Headlines Receive PLLWF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:PLLWF CUSIPN/A CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Kenneth Paul West (Age 67)Chairman of the Board Comp: $56.75kDr. Bastiaan Driehuys Ph.D. (Age 54)Founder, Chief Scientific Officer & Director Comp: $36.5kMr. Charles Fremont Osborne Jr. (Age 58)CFO & Director Comp: $342.11kDr. Christopher Richard Von Jako Ph.D. (Age 54)CEO & Director Mr. Neil Wadehra (Age 44)Vice President of Operations Mr. Alex Dusek (Age 57)Chief Commercial Officer Mr. Stephen AustinCompany SecretaryMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors PLLWF Stock Analysis - Frequently Asked Questions How have PLLWF shares performed in 2024? Polarean Imaging's stock was trading at $0.09 at the beginning of 2024. Since then, PLLWF shares have decreased by 42.2% and is now trading at $0.0520. View the best growth stocks for 2024 here. How do I buy shares of Polarean Imaging? Shares of PLLWF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PLLWF) was last updated on 5/27/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlacePOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchWARNING about the death of the U.S. dollar…Colonial MetalsMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
